The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer
The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.
Study Type
OBSERVATIONAL
Enrollment
10,885
Lobectomy or segment/wedge dissection
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
China People's Liberation Army Hospital
Beijing, Beijing Municipality, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Overall survival
Overall survival
Time frame: 2015-2017
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, China
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Huaxi Hospital Affiliate to Sichuan University
Chengdu, Sichuan, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, China